Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chretien

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Journal of Medical Genetics|July 15, 2006
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European AmericansJ-P Chretien, J Coresh, Y Berthier-Schaad, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 1997
Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gammaL Phan-Bich, A Buard, J F Petit, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1981
Effect of splenectomy of hepatic bilirubin clearance in patients with hereditary spherocytosis. Implications for the diagnosis of Gilbert's syndromeP D Berk, M D Berman, B L Blitzer, et al.
Annals of the New York Academy of Sciences|July 15, 2005
Diagnostic value of anti-F-actin antibodies in a French multicenter studyP Chretien-Leprince, E Ballot, C Andre, et al.
Scandinavian Journal of Immunology|November 20, 2016
The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic SclerosisF Tall, M Dechomet, S Riviere, et al.
Autoimmunity Reviews|March 31, 2011
Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric studyP Ghillani, C André, C Toly, et al.
The Laryngoscope|December 9, 2003
The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical TrialJózsef Tímár, C Forster-Horváth, J Lukits, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Journal of Medical Genetics|July 15, 2006
Three single-nucleotide polymorphisms in LPA account for most of the increase in lipoprotein(a) level elevation in African Americans compared with European AmericansJ-P Chretien, J Coresh, Y Berthier-Schaad, et al.
American Journal of Respiratory Cell and Molecular Biology|February 1, 1997
Differential responsiveness of human and rat mesothelioma cell lines to recombinant interferon-gammaL Phan-Bich, A Buard, J F Petit, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1981
Effect of splenectomy of hepatic bilirubin clearance in patients with hereditary spherocytosis. Implications for the diagnosis of Gilbert's syndromeP D Berk, M D Berman, B L Blitzer, et al.
Annals of the New York Academy of Sciences|July 15, 2005
Diagnostic value of anti-F-actin antibodies in a French multicenter studyP Chretien-Leprince, E Ballot, C Andre, et al.
Scandinavian Journal of Immunology|November 20, 2016
The Clinical Relevance of Antifibrillarin (anti-U3-RNP) Autoantibodies in Systemic SclerosisF Tall, M Dechomet, S Riviere, et al.
Autoimmunity Reviews|March 31, 2011
Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric studyP Ghillani, C André, C Toly, et al.
The Laryngoscope|December 9, 2003
The effect of leukocyte interleukin injection (Multikine) treatment on the peritumoral and intratumoral subpopulation of mononuclear cells and on tumor epithelia: a possible new approach to augmenting sensitivity to radiation therapy and chemotherapy in oral cancer--a multicenter phase I/II clinical TrialJózsef Tímár, C Forster-Horváth, J Lukits, et al.
Pageof 6